Talk:MitoGlobal Centres: Difference between revisions

@@ Line 68: / Line 68: @@
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories France| France]]
+|[[MitoGlobal Centres France| France]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Germany| Germany]]
+|[[MitoGlobal Centres Germany| Germany]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Hungary| Hungary]]
+|[[MitoGlobal Centres Hungary| Hungary]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
@@ Line 85: / Line 85: @@
 |-
 |-
-|[[MiPNet Laboratories India| India]]
+|[[MitoGlobal Centres India| India]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Ireland| Ireland]]
+|[[MitoGlobal Centres Ireland| Ireland]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Italy| Italy]]
+|[[MitoGlobal Centres Italy| Italy]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Japan| Japan]]
+|[[MitoGlobal Centres Japan| Japan]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Lithuania| Lithuania]]
+|[[MitoGlobal Centres Lithuania| Lithuania]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Netherlands| Netherlands]]
+|[[MitoGlobal Centres Netherlands| Netherlands]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories New Zealand| New Zealand]]
+|[[MitoGlobal Centres New Zealand| New Zealand]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Norway| Norway]]
+|[[MitoGlobal Centres Norway| Norway]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
@@ Line 127: / Line 127: @@
 |-
 |-
-|[[MiPNet Laboratories Poland| Poland]]
+|[[MitoGlobal Centres Poland| Poland]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Romania| Romania]]
+|[[MitoGlobal Centres Romania| Romania]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Russia| Russia]]
+|[[MitoGlobal Centres Russia| Russia]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Singapore| Singapore]]
+|[[MitoGlobal Centres Singapore| Singapore]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Slovak Republic| Slovak Republic]]
+|[[MitoGlobal Centres Slovak Republic| Slovak Republic]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories South Africa| South Africa]]
+|[[MitoGlobal Centres South Africa| South Africa]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories South Korea| South Korea]]
+|[[MitoGlobal Centres South Korea| South Korea]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Spain| Spain]]
+|[[MitoGlobal Centres Spain| Spain]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
@@ Line 169: / Line 169: @@
 |-
 |-
-|[[MiPNet Laboratories Sweden| Sweden]]
+|[[MitoGlobal Centres Sweden| Sweden]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Switzerland | Switzerland]]
+|[[MitoGlobal Centres Switzerland | Switzerland]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories United Kingdom| United Kingdom]]
+|[[MitoGlobal Centres United Kingdom| United Kingdom]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories Uruguay| Uruguay]]
+|[[MitoGlobal Centres Uruguay| Uruguay]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;
-|[[MiPNet Laboratories USA| USA]]
+|[[MitoGlobal Centres USA| USA]]
 |&nbsp;&nbsp;&nbsp;
 |&nbsp;&nbsp;&nbsp;